会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Disc spring and process of manufacturing the same
    • 盘簧和制造过程相同
    • US08530779B2
    • 2013-09-10
    • US12833603
    • 2010-07-09
    • Eiji MizunoYuichi Hirata
    • Eiji MizunoYuichi Hirata
    • B23K15/00F16F1/34
    • F16F1/32B23K15/0006B23K15/0033
    • A metal strip 10 is bent to form a ring and end parts 12 and 14 are connected to each other. An electron beam 26 may be defocused and emitted to a welded section 20 along a crosswise direction of the metal strip 10. Next, a focal point 28 of the electron beam 26 may be focused onto a weld-melted portion 25 to execute electron beam welding. Subsequently, the electron beam 26 may be defocused emitted to the welded section 20 along the crosswise direction of the metal strip 10, and the welded section 20 may be further cooled. The average of the dendrite secondary arm spacing of the weld-melted portion may fall within a range of 7 to 30 μm.
    • 金属带10被弯曲以形成环,端部12和14彼此连接。 电子束26可以沿着金属条10的横向方向散焦并发射到焊接部分20.接下来,电子束26的焦点28可以聚焦到焊接熔化部分25上以执行电子束焊接 。 随后,电子束26可以沿着金属带10的横向发射到焊接部分20,并且可以进一步冷却焊接部分20。 熔融熔融部分的枝晶次臂间距的平均值可以在7〜30μm的范围内。
    • 6. 发明授权
    • Steroid hormone binding protein
    • 类固醇激素结合蛋白
    • US06432674B1
    • 2002-08-13
    • US09565808
    • 2000-05-05
    • Yuichi Hirata
    • Yuichi Hirata
    • C12P2106
    • G01N33/743C07K14/721
    • Several ESTs deduced as a part of a cDNA encoding a protein that is homologous with a membrane-bound steroid binding protein PMBP were found. Based on the sequence data of these ESTs, a consensus sequence was extracted, and primers were designed based on this consensus sequence. Using the thus designed primers, a polymerase chain reaction of human genes was effected. As a result, a gene encoding a novel steroid hormone binding protein that is homologous with PMBP was successfully isolated from a human for the first time.
    • 发现几种EST被推定为编码与膜结合的类固醇结合蛋白PMBP同源的蛋白质的cDNA的一部分。 基于这些EST的序列数据,提取了共有序列,并基于该共有序列设计引物。 使用如此设计的引物,进行人基因的聚合酶链反应。 结果,与人类第一次成功分离了编码与PMBP同源的新型类固醇激素结合蛋白的基因。
    • 10. 发明授权
    • Ligand having agonistic activity to mutated receptor
    • 配体对突变受体具有激动作用
    • US07691588B2
    • 2010-04-06
    • US10548727
    • 2004-03-12
    • Masayuki TsuchiyaYuichi Hirata
    • Masayuki TsuchiyaYuichi Hirata
    • G01N33/53G01N33/574G01N33/576C12P21/08C07K16/00
    • C09K11/7733G21K4/00
    • The present inventors used antibody engineering techniques to prepare functional antibodies that correspond to individual mutations in causative genes of diseases, and discovered that such antibodies enable the treatment of the diseases. Specifically, the inventors succeeded in preparing ligands, particularly minibodies, which have agonistic activity to receptors that have almost completely lost responsiveness to their natural ligands because of gene mutations (for example, a thrombopoietin (TPO) receptor whose reactivity to TPO has been markedly impaired), and which can transduce signals by interacting with these mutant receptors at levels comparable to normal.
    • 本发明人使用抗体工程技术来制备与疾病的致病基因中的个体突变相对应的功能性抗体,并发现这种抗体能够治疗疾病。 具体地,本发明人成功地制备了由于基因突变(例如,其对TPO的反应性已被显着损伤的血小板生成素(TPO)受体)而对几乎完全丧失对其天然配体的反应性的受体具有激动作用的配体,特别是微型抗体 ),并且其可以通过与这些突变体受体的相互作用来转导信号,其水平与正常水平相当。